Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
Identifieur interne : 001285 ( Main/Exploration ); précédent : 001284; suivant : 001286Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
Auteurs : Sun In Hong [Corée du Sud] ; Byung-Han Ryu [Corée du Sud] ; Yong Pil Chong [Corée du Sud] ; Seungjun Lee [Corée du Sud] ; Sunjoo Kim [Corée du Sud] ; Ho Cheol Kim [Corée du Sud] ; Kyung-Wook Hong [Corée du Sud] ; In-Gyu Bae [Corée du Sud] ; Oh-Hyun Cho [Corée du Sud]Source :
- International journal of antimicrobial agents [ 1872-7913 ] ; 2020.
Descripteurs français
- KwdFr :
- Adjuvants immunologiques (administration et posologie), Adulte (MeSH), Adulte d'âge moyen (MeSH), Antipaludiques (administration et posologie), Antiviraux (administration et posologie), Association de médicaments (méthodes), Betacoronavirus (croissance et développement), Femelle (MeSH), Humains (MeSH), Hydroxychloroquine (administration et posologie), Infections à coronavirus (anatomopathologie), Infections à coronavirus (traitement médicamenteux), Interféron bêta-1b (administration et posologie), Lopinavir (administration et posologie), Mâle (MeSH), Pandémies (MeSH), Pneumopathie infectieuse (traitement médicamenteux), Pneumopathie virale (anatomopathologie), Pneumopathie virale (traitement médicamenteux), Ritonavir (administration et posologie), Résultat thérapeutique (MeSH), Sujet âgé (MeSH).
- MESH :
- administration et posologie : Adjuvants immunologiques, Antipaludiques, Antiviraux, Hydroxychloroquine, Interféron bêta-1b, Lopinavir, Ritonavir.
- anatomopathologie : Infections à coronavirus, Pneumopathie virale.
- croissance et développement : Betacoronavirus.
- méthodes : Association de médicaments.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie infectieuse, Pneumopathie virale.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Mâle, Pandémies, Résultat thérapeutique, Sujet âgé.
English descriptors
- KwdEn :
- Adjuvants, Immunologic (administration & dosage), Adult (MeSH), Aged (MeSH), Antimalarials (administration & dosage), Antiviral Agents (administration & dosage), Betacoronavirus (growth & development), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (pathology), Drug Therapy, Combination (methods), Female (MeSH), Humans (MeSH), Hydroxychloroquine (administration & dosage), Interferon beta-1b (administration & dosage), Lopinavir (administration & dosage), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia (drug therapy), Pneumonia, Viral (drug therapy), Pneumonia, Viral (pathology), Ritonavir (administration & dosage), SARS-CoV-2 (MeSH), Treatment Outcome (MeSH).
- MESH :
- chemical , administration & dosage : Adjuvants, Immunologic, Antimalarials, Antiviral Agents, Hydroxychloroquine, Interferon beta-1b, Lopinavir, Ritonavir.
- drug therapy : Coronavirus Infections, Pneumonia, Pneumonia, Viral.
- growth & development : Betacoronavirus.
- methods : Drug Therapy, Combination.
- pathology : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, COVID-19, Female, Humans, Male, Middle Aged, Pandemics, SARS-CoV-2, Treatment Outcome.
DOI: 10.1016/j.ijantimicag.2020.106052
PubMed: 32544570
PubMed Central: PMC7293467
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.</title>
<author><name sortKey="Hong, Sun In" sort="Hong, Sun In" uniqKey="Hong S" first="Sun In" last="Hong">Sun In Hong</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ryu, Byung Han" sort="Ryu, Byung Han" uniqKey="Ryu B" first="Byung-Han" last="Ryu">Byung-Han Ryu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chong, Yong Pil" sort="Chong, Yong Pil" uniqKey="Chong Y" first="Yong Pil" last="Chong">Yong Pil Chong</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lee, Seungjun" sort="Lee, Seungjun" uniqKey="Lee S" first="Seungjun" last="Lee">Seungjun Lee</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kim, Sunjoo" sort="Kim, Sunjoo" uniqKey="Kim S" first="Sunjoo" last="Kim">Sunjoo Kim</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kim, Ho Cheol" sort="Kim, Ho Cheol" uniqKey="Kim H" first="Ho Cheol" last="Kim">Ho Cheol Kim</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hong, Kyung Wook" sort="Hong, Kyung Wook" uniqKey="Hong K" first="Kyung-Wook" last="Hong">Kyung-Wook Hong</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bae, In Gyu" sort="Bae, In Gyu" uniqKey="Bae I" first="In-Gyu" last="Bae">In-Gyu Bae</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cho, Oh Hyun" sort="Cho, Oh Hyun" uniqKey="Cho O" first="Oh-Hyun" last="Cho">Oh-Hyun Cho</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: zenmd@naver.com.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32544570</idno>
<idno type="pmid">32544570</idno>
<idno type="doi">10.1016/j.ijantimicag.2020.106052</idno>
<idno type="pmc">PMC7293467</idno>
<idno type="wicri:Area/Main/Corpus">001396</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001396</idno>
<idno type="wicri:Area/Main/Curation">001396</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001396</idno>
<idno type="wicri:Area/Main/Exploration">001396</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.</title>
<author><name sortKey="Hong, Sun In" sort="Hong, Sun In" uniqKey="Hong S" first="Sun In" last="Hong">Sun In Hong</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ryu, Byung Han" sort="Ryu, Byung Han" uniqKey="Ryu B" first="Byung-Han" last="Ryu">Byung-Han Ryu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chong, Yong Pil" sort="Chong, Yong Pil" uniqKey="Chong Y" first="Yong Pil" last="Chong">Yong Pil Chong</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lee, Seungjun" sort="Lee, Seungjun" uniqKey="Lee S" first="Seungjun" last="Lee">Seungjun Lee</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kim, Sunjoo" sort="Kim, Sunjoo" uniqKey="Kim S" first="Sunjoo" last="Kim">Sunjoo Kim</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon</wicri:regionArea>
<wicri:noRegion>Changwon</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kim, Ho Cheol" sort="Kim, Ho Cheol" uniqKey="Kim H" first="Ho Cheol" last="Kim">Ho Cheol Kim</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hong, Kyung Wook" sort="Hong, Kyung Wook" uniqKey="Hong K" first="Kyung-Wook" last="Hong">Kyung-Wook Hong</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bae, In Gyu" sort="Bae, In Gyu" uniqKey="Bae I" first="In-Gyu" last="Bae">In-Gyu Bae</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cho, Oh Hyun" sort="Cho, Oh Hyun" uniqKey="Cho O" first="Oh-Hyun" last="Cho">Oh-Hyun Cho</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: zenmd@naver.com.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju</wicri:regionArea>
<wicri:noRegion>Jinju</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of antimicrobial agents</title>
<idno type="eISSN">1872-7913</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (administration & dosage)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Antimalarials (administration & dosage)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Betacoronavirus (growth & development)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (pathology)</term>
<term>Drug Therapy, Combination (methods)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (administration & dosage)</term>
<term>Interferon beta-1b (administration & dosage)</term>
<term>Lopinavir (administration & dosage)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia (drug therapy)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (pathology)</term>
<term>Ritonavir (administration & dosage)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (administration et posologie)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Antipaludiques (administration et posologie)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Association de médicaments (méthodes)</term>
<term>Betacoronavirus (croissance et développement)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (administration et posologie)</term>
<term>Infections à coronavirus (anatomopathologie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Interféron bêta-1b (administration et posologie)</term>
<term>Lopinavir (administration et posologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie infectieuse (traitement médicamenteux)</term>
<term>Pneumopathie virale (anatomopathologie)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Ritonavir (administration et posologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adjuvants, Immunologic</term>
<term>Antimalarials</term>
<term>Antiviral Agents</term>
<term>Hydroxychloroquine</term>
<term>Interferon beta-1b</term>
<term>Lopinavir</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Adjuvants immunologiques</term>
<term>Antipaludiques</term>
<term>Antiviraux</term>
<term>Hydroxychloroquine</term>
<term>Interféron bêta-1b</term>
<term>Lopinavir</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy, Combination</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Association de médicaments</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie infectieuse</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>COVID-19</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32544570</PMID>
<DateCompleted><Year>2020</Year>
<Month>08</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7913</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>56</Volume>
<Issue>2</Issue>
<PubDate><Year>2020</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>International journal of antimicrobial agents</Title>
<ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation>
</Journal>
<ArticleTitle>Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.</ArticleTitle>
<Pagination><MedlinePgn>106052</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0924-8579(20)30222-3</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2020.106052</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName>
<ForeName>Sun In</ForeName>
<Initials>SI</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ryu</LastName>
<ForeName>Byung-Han</ForeName>
<Initials>BH</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chong</LastName>
<ForeName>Yong Pil</ForeName>
<Initials>YP</Initials>
<AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Seungjun</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Sunjoo</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Ho Cheol</ForeName>
<Initials>HC</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hong</LastName>
<ForeName>Kyung-Wook</ForeName>
<Initials>KW</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bae</LastName>
<ForeName>In-Gyu</ForeName>
<Initials>IG</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cho</LastName>
<ForeName>Oh-Hyun</ForeName>
<Initials>OH</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic address: zenmd@naver.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Int J Antimicrob Agents</MedlineTA>
<NlmUniqueID>9111860</NlmUniqueID>
<ISSNLinking>0924-8579</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>145155-23-3</RegistryNumber>
<NameOfSubstance UI="D000068576">Interferon beta-1b</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000254" MajorTopicYN="Y">growth & development</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068576" MajorTopicYN="N">Interferon beta-1b</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">Interferon</Keyword>
<Keyword MajorTopicYN="N">Lopinavir/ritonavir</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>05</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32544570</ArticleId>
<ArticleId IdType="pii">S0924-8579(20)30222-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106052</ArticleId>
<ArticleId IdType="pmc">PMC7293467</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2020 Apr;20(4):400-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32113509</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2020 Jun;26(6):1345-1348</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32118533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2020 Jul 1;180(7):934-943</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Nov 19;71(16):2114-2120</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32427279</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Corée du Sud</li>
</country>
<region><li>Région capitale de Séoul</li>
</region>
<settlement><li>Séoul</li>
</settlement>
</list>
<tree><country name="Corée du Sud"><noRegion><name sortKey="Hong, Sun In" sort="Hong, Sun In" uniqKey="Hong S" first="Sun In" last="Hong">Sun In Hong</name>
</noRegion>
<name sortKey="Bae, In Gyu" sort="Bae, In Gyu" uniqKey="Bae I" first="In-Gyu" last="Bae">In-Gyu Bae</name>
<name sortKey="Cho, Oh Hyun" sort="Cho, Oh Hyun" uniqKey="Cho O" first="Oh-Hyun" last="Cho">Oh-Hyun Cho</name>
<name sortKey="Chong, Yong Pil" sort="Chong, Yong Pil" uniqKey="Chong Y" first="Yong Pil" last="Chong">Yong Pil Chong</name>
<name sortKey="Hong, Kyung Wook" sort="Hong, Kyung Wook" uniqKey="Hong K" first="Kyung-Wook" last="Hong">Kyung-Wook Hong</name>
<name sortKey="Kim, Ho Cheol" sort="Kim, Ho Cheol" uniqKey="Kim H" first="Ho Cheol" last="Kim">Ho Cheol Kim</name>
<name sortKey="Kim, Sunjoo" sort="Kim, Sunjoo" uniqKey="Kim S" first="Sunjoo" last="Kim">Sunjoo Kim</name>
<name sortKey="Lee, Seungjun" sort="Lee, Seungjun" uniqKey="Lee S" first="Seungjun" last="Lee">Seungjun Lee</name>
<name sortKey="Ryu, Byung Han" sort="Ryu, Byung Han" uniqKey="Ryu B" first="Byung-Han" last="Ryu">Byung-Han Ryu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001285 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001285 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32544570 |texte= Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32544570" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |